百花医药公告：实控人筹划股份转让

Core Viewpoint - Baihua Pharmaceutical (600721.SH), a company specializing in pharmaceutical research and development services (CRO), announced that it received a notification from its controlling shareholders regarding the planning of a share transfer agreement, which may lead to a change in the company's control [1] Group 1 - The company is involved in the pharmaceutical research and development services sector [1] - The controlling shareholders include Mi Zaiqi, Mi Enhua, and Yang Xiaoling [1] - The potential share transfer could significantly impact the company's governance structure [1]